Tag: CORO
Nirmatrelvir/Ritonavir Cuts COVID-19 Complications in Highest-Risk Patients
Risk for COVID-19 hospitalization or death reduced for those who were severely or moderately immunocompromised
In-Hospital Mortality Evaluated for SARS-CoV-2-Linked Sepsis
March 2020 to November 2022 saw decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9 percent
COVID-19 Infection, Vaccination Have Little Effect on Migraine Worsening
Increased concern about migraine worsening was risk factor for perceived migraine worsening
FDA Approves Updated Novavax COVID-19 Vaccine
Updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus
Maternal Psychosocial Stress, COVID-19 Infection Tied to Infant Attentional Processing
Findings revealed lower infant attention scores at six months, which predicted socioemotional function, neurodevelopmental risk
Maternal COVID-19 Vaccination Provides Some Protection for Infants
Some protection against COVID-19-related hospitalizations seen among infants, especially those aged younger than 3 months
Infection With Omicron Less Likely to Result in Post-COVID-19 Condition
No variation in risk for PCC seen based on number of vaccinations, but previous infection linked to reduced PCC risk
BNT162b2 Vaccination Linked to Lower Risk for COVID-19 Encounters in Children Under 5
Vaccination linked to reduced odds ratio of COVID-19-related emergency department or urgent care encounter, outpatient visits
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Similar immune response and no increase in rate of reactogenicity events seen with coadministration versus COVID-19 vaccine alone
CDC Panel Gives Support to New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
